Residual Impurity Testing
Residual Impurity Testing is a quality assurance method used in pharmaceutical development that specifically identifies and quantifies trace contaminants remaining in a drug substance or product after purification processes.
14
Publications
440
Citations
54
Authors
14
Institutions
Publications per year
2017–2026
2
Parents
14
Akito Kuramata, Kimiyoshi Koshi, Shinya Watanabe et al. · 2018 · 38 citations
Natural Sciences, Materials Engineering, Materials Science +17
1–5 of 14
54
2
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 54
14
University of Illinois Urbana-Champaign
Urbana, United States
2 h-index
6 publications
152 citations
Toshiba (Japan)
Tokyo, Japan
2 h-index
4 publications
80 citations

KTH Royal Institute of Technology
Stockholm, Sweden
1 h-index
1 publications
29 citations

Tohoku University
Sendai, Japan
1 h-index
3 publications
78 citations
Fujitsu (Japan)
Kawasaki, Japan
1 h-index
3 publications
111 citations

Washington University in St. Louis
St Louis, United States
1 h-index
1 publications
22 citations

China Pharmaceutical University
Nanjing, China
1 h-index
5 publications
65 citations
Fera Science (United Kingdom)
York, United Kingdom
1 h-index
3 publications
66 citations
1–8 of 14
2 publications · 66 citations
2
h-index
2 publications · 49 citations
2
h-index
JEM · 1 publications · 140 citations
1
h-index
1 publications · 14 citations
1
h-index
1 publications · 13 citations
1
h-index
1–5